KANSAS CITY, Mo., March 15, 2022 /PRNewswire/ -- Cerner
Corporation (Nasdaq: CERN), a global healthcare technology
company, today announced that its Board of Directors (the "Board")
declared a cash dividend to stockholders of $0.27 per issued and outstanding share. The cash
dividend will be payable April 19,
2022, to shareholders of record as of the close of business
March 28, 2022.
Cerner intends to pay regular quarterly cash dividends, with
future declarations subject to Board approval and their
determination that the declaration of dividends remains in the best
interests of Cerner and its shareholders. The decision of whether
to pay future dividends and the amount of any such dividends will
be based on the company's financial position, results of
operations, cash flows, capital requirements, applicable law and
any other factors the Board may deem relevant.
About Cerner
Cerner's health technologies connect people and information
systems at thousands of contracted provider facilities worldwide
dedicated to creating smarter and better care for individuals and
communities. Recognized globally for innovation, Cerner assists
clinicians in making care decisions and assists organizations in
managing the health of their populations. The company also offers a
connected clinical and financial ecosystem to help manage
day-to-day revenue functions, as well as a wide range of services
to support clinical, financial and operational needs, focused on
people. For more information, visit Cerner.com, Cerner
Perspectives, connect on Facebook, Instagram, LinkedIn, Twitter or
join the discussion on Cerner's podcast Perspectives on Health
& Tech. Nasdaq: CERN. Healthcare is too important to stay the
same.
Cautionary Statement Regarding Forward-Looking
Statements
All statements in this press release that do not directly and
exclusively relate to historical facts constitute forward-looking
statements. These forward-looking statements are based on the
current beliefs, expectations and assumptions of Cerner's
management with respect to future events and are subject to a
number of significant risks and uncertainties. It is important to
note that Cerner's performance, and actual results, financial
condition or business could differ materially from those expressed
in such forward- looking statements. The words "intends," "future,"
or the negative of these words, variations thereof or similar
expressions are intended to identify such forward-looking
statements. For example, our forward-looking statements include
statements regarding future dividends. Factors that could cause or
contribute to such differences include, but are not limited to the
potential disruptions to our business caused by the proposed
acquisition of us by Oracle Corporation; the possibility that the
proposed acquisition will not close or that the closing may be
delayed; stockholder litigation could prevent or delay the closing
of the transaction or otherwise impact our business, operating
results and financial condition; the impact of the COVID-19
pandemic on how Cerner and its customers are operating their
businesses and the duration and extent to which the pandemic will
impact Cerner's future results of operations; the possibility of
interruption at our data centers or client support facilities, or
those of third parties with whom we have contracted (such as public
cloud providers), that could expose us to significant costs and
reputational harm and interrupt client's access to their data; the
possibility of increased expenses, exposure to legal claims and
regulatory actions and reputational harm associated with a security
breach; potential claims for system errors and warranties or
significant costs and reputational harm related to product and
service-related liabilities; material adverse resolution of legal
proceedings or other claims or reputational harm stemming from
negative publicity related to such claims or legal proceedings; the
possibility that Cerner may be adversely affected by other
economic, business, and/or competitive factors, including our
ability to anticipate or respond quickly to market changes,
changing technologies and evolving pricing and deployment methods
and to bring competitive new solutions, devices, features and
services to market in a timely fashion; risks inherent with
business acquisitions, strategic investments, collaborations and
the failure to achieve projected synergies, or divestitures;
managing growth in the new markets in which we offer solutions,
health care devices or services; long sales cycles for our
solutions and services; risks related to our dependence on
strategic relationships and third party suppliers, including any
impact to such supplier's business resulting from the COVID-19
pandemic; the ability of Cerner to attract or retain customers and
key personnel and to maintain relationships with key suppliers;
inability to achieve expected operating efficiencies and sustain or
improve operating expense reductions or business disruptions or
adverse tax consequences associated with restructuring, realignment
and costs reduction activities; changing political, economic and
regulatory influences, which could impact the purchasing practices
and operations of our clients and increase costs to deliver
compliant solutions and services; non-compliance with laws,
regulations or certain industry initiatives or failure to deliver
solutions or services that enable our clients to comply with laws
or regulations applicable to their businesses; risks inherent in
contracting with government clients, including without limitation,
complying with strict compliance and disclosure obligations,
navigating complex procurement rules and processes, and defending
against bid protests; risks associated with our outstanding and
future indebtedness, such as compliance with restrictive covenants,
which may limit our flexibility to operate our business; risk that
our capital allocation strategy will not be fully implemented or
enhance long-term shareholder value; changes in tax laws,
regulations or guidance that could adversely affect our tax
position and/or challenges to our tax positions in the U.S. and
non-U.S. countries; possibility that our transition to a
subscription based recurring revenue model and continued
modernization of our technology may adversely affect our near-term
revenue growth and results of operations; the potential for losses
resulting from asset impairment charges; potential variations in
our sales forecasts compared to actual sales; risks that our
revenue growth may be lower than anticipated and/or that the mix of
revenue shifts to low margin revenue; variations in our quarterly
operating results; and risks associated with fluctuations in
foreign currency exchange rates. Additional discussion of these and
other risks, uncertainties and factors affecting Cerner's business
is contained in Cerner's filings with the Securities and Exchange
Commission. The reader should not place undue reliance on
forward-looking statements, since the statements speak only as of
the date that they are made. Except as required by law, Cerner
undertakes no obligation to update or revise forward-looking
statements to reflect changed assumptions, the occurrence of
unanticipated events, or changes in our business, results of
operations or financial condition over time.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/cerner-announces-quarterly-dividend-301502899.html
SOURCE Cerner Corp.